Results 261 to 270 of about 33,699 (271)

Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD

Chest, 2017
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson   +2 more
exaly  

RCT Abstract - Budesonide/glycopyrronium/formoterol fumarate dihydrate triple therapy for inadequately-controlled asthma: KALOS and LOGOS study results

Airway pharmacology and treatment
A. Papi, Robert Wise, David J Jackson, N. Lugogo, Ruchong Chen, T. Trasieva, C. Obasi, C. Movitz, J. Helman, P. Salter, K. Springer, M. Bondoc, Mihir Shah, K. Knappenberger, K. Bowen, H. Pandya, A. Megally, M. Patel   +17 more
semanticscholar   +1 more source

Formoterol Fumarate Inhalation Solution

openaire   +1 more source

Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate in Chinese Patients With Chronic Obstructive Pulmonary Disease

B52. EVIDENCE FOR THERAPEUTIC STRATEGIES IN COPD: FROM ESTABLISHED TO EMERGING
Y. Sun, Y. Chen, L. Zhou, X. Zhang, R. Guo, J. Feng, X. Xiong, G. Li, W. Xu, J. Zhang   +9 more
semanticscholar   +1 more source

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

Lancet, The, 2001
exaly  

Systemic Exposure Bioequivalence of Budesonide/Glycopyrrolate/Formoterol Fumarate With the Potential Next Generation Propellant Hydrofluoroolefin-1234ze Versus Hydrofluoroalkane-134a in Healthy Adults

B52. EVIDENCE FOR THERAPEUTIC STRATEGIES IN COPD: FROM ESTABLISHED TO EMERGING
M. Shah, M. Aurivillius, I. Raphiou, D. Petullo, J. Xu, A. Bednarczyk, K. Sychowicz, K. Collison, C. Silva, J. Reddy, D. Han, M. Gillen   +11 more
semanticscholar   +1 more source

Lung Exposure Bioequivalence With Budesonide/Glycopyrrolate/Formoterol Fumarate With the Next Generation Propellant Hydrofluoroolefin-1234ze Versus Hydrofluoroalkane-134a in Healthy Adults: A Charcoal Block Study

A27. EMERGING TREATMENTS AND THERAPEUTIC STRATEGIES IN COPD: RESULTS OF CLINICAL TRIALS AND OBSERVATIONAL STUDIES
I. Raphiou, M. Aurivillius, D. Petullo, J. Xu, A. Bednarczyk, K. Sychowicz, K. Collison, C. Silva, J. Reddy, R. Goldwater, M. Gillen   +10 more
semanticscholar   +1 more source

EFFECTIVENESS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN CHINESE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN REAL-WORLD CLINICAL PRACTICE

Chest
Yongchang Sun, Yunfeng Chen, Xiuwei Zhang, R. Guo, Luqian Zhou, Jiaxi Feng, X. Xiong, Weiguo Xu, Guoping Li, Jing Zhang   +9 more
semanticscholar   +1 more source

Adherence and Persistence with Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate Among Patients with Chronic Obstructive Pulmonary Disease: A Real-world United States Study

B32. BIOMARKERS AND TRANSLATIONAL STUDIES IN COPD AND CHRONIC AIRWAYS DISEASES
S. Noorduyn, C. Young, L. Lee, G. Germain, F. Laliberté, D. Lejeune, J. Klimek, K. DiRocco, R. Paczkowski   +8 more
semanticscholar   +1 more source

Effect of Triple Inhaled Therapy With Budesonide/Glycopyrrolate/Formoterol Fumarate on Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post-hoc Analysis of ETHOS

A27. EMERGING TREATMENTS AND THERAPEUTIC STRATEGIES IN COPD: RESULTS OF CLINICAL TRIALS AND OBSERVATIONAL STUDIES
D. Singh, F. Martinez, J. R. Hurst, M.K. Han, C.P. Gale, M. Fredriksson, D. Kisielewicz, A. Mushunje, C. Movitz, N. Ojili, H. Parikh, N. Arya, K. Bowen, M. Patel   +13 more
semanticscholar   +1 more source